JP2014502508A5 - - Google Patents

Download PDF

Info

Publication number
JP2014502508A5
JP2014502508A5 JP2013546763A JP2013546763A JP2014502508A5 JP 2014502508 A5 JP2014502508 A5 JP 2014502508A5 JP 2013546763 A JP2013546763 A JP 2013546763A JP 2013546763 A JP2013546763 A JP 2013546763A JP 2014502508 A5 JP2014502508 A5 JP 2014502508A5
Authority
JP
Japan
Prior art keywords
poliovirus
stem
base pairs
positions
coding region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013546763A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014502508A (ja
JP5955860B2 (ja
Filing date
Publication date
Priority claimed from GBGB1022077.0A external-priority patent/GB201022077D0/en
Application filed filed Critical
Publication of JP2014502508A publication Critical patent/JP2014502508A/ja
Publication of JP2014502508A5 publication Critical patent/JP2014502508A5/ja
Application granted granted Critical
Publication of JP5955860B2 publication Critical patent/JP5955860B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013546763A 2010-12-29 2011-12-29 不活化ポリオワクチン Active JP5955860B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1022077.0 2010-12-29
GBGB1022077.0A GB201022077D0 (en) 2010-12-29 2010-12-29 Inactivated poliovaccine
PCT/GB2011/001779 WO2012090000A1 (en) 2010-12-29 2011-12-29 Inactivated poliovaccine

Publications (3)

Publication Number Publication Date
JP2014502508A JP2014502508A (ja) 2014-02-03
JP2014502508A5 true JP2014502508A5 (https=) 2014-12-18
JP5955860B2 JP5955860B2 (ja) 2016-07-20

Family

ID=43599090

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013546763A Active JP5955860B2 (ja) 2010-12-29 2011-12-29 不活化ポリオワクチン

Country Status (13)

Country Link
US (1) US9402892B2 (https=)
EP (1) EP2658571B1 (https=)
JP (1) JP5955860B2 (https=)
CN (1) CN103391788B (https=)
AU (1) AU2011350995B2 (https=)
BR (1) BR112013017014B1 (https=)
CA (1) CA2821859C (https=)
DK (1) DK2658571T3 (https=)
ES (1) ES2574178T3 (https=)
GB (1) GB201022077D0 (https=)
RU (1) RU2599453C2 (https=)
WO (1) WO2012090000A1 (https=)
ZA (1) ZA201304415B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0615933D0 (en) 2006-08-10 2006-09-20 Nat Inst Biological Standards & Control Attenuated polioviruses
AU2015276235B2 (en) * 2014-06-17 2021-02-18 Janssen Vaccines & Prevention B.V. Cold-Adapted-Viral-Attenuation (CAVA) and novel attenuated Poliovirus strains
GB201700825D0 (en) * 2017-01-17 2017-03-01 Sec Dep For Health Poliovaccine
CN119055763A (zh) * 2018-03-30 2024-12-03 生物模仿公司 辐照灭活的脊髓灰质炎病毒、包含其的组合物及制备方法
WO2020075197A1 (en) * 2018-10-10 2020-04-16 Biological E Limited Inactivated poliomyelitis vaccine composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8901094D0 (en) 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
ZA929418B (en) * 1991-12-06 1993-06-07 Whitehead Biomedical Inst Recombinant vaccines and method of producing same.
GB9705669D0 (en) 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
GB9817082D0 (en) * 1998-08-06 1998-10-07 Btg Int Ltd Attenuated poliovirus vaccine
GB0615933D0 (en) * 2006-08-10 2006-09-20 Nat Inst Biological Standards & Control Attenuated polioviruses

Similar Documents

Publication Publication Date Title
HRP20140597T1 (hr) Proizvodnja polio virusa u visokim titrima za proizvodnju cjepiva
Drew The emergence and evolution of swine viral diseases: to what extent have husbandry systems and global trade contributed to their distribution and diversity?
JP2014502508A5 (https=)
Vu et al. A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection
JP2014532691A5 (https=)
Hankaniemi et al. Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model
Holmblat et al. Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses
NZ577405A (en) Vaccines including antigen from four strains of influenza virus
JP2013520977A5 (https=)
CN105517568B (zh) 防止病毒组分聚集的方法
Fang et al. Novel strategies for the development of hand, foot, and mouth disease vaccines and antiviral therapies
JP2015517304A5 (https=)
Sun et al. Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils
CN107460156A (zh) 无血清全悬浮mdck细胞株及其在生产流感病毒中的应用
RU2013135290A (ru) Инактивированная полиовакцина
CN106636001B (zh) 一种重组肠道病毒表型混合系统的构建方法和应用
Sanders et al. Production of high titer attenuated poliovirus strains on the serum-free PER. C6® cell culture platform for the generation of safe and affordable next generation IPV
EA201692468A1 (ru) Аттенуация вируса путем холодовой адаптации (cava) и новые аттенуированные штаммы полиовируса
EA200701695A1 (ru) Рнк вирусы с ослабленной способностью к репликации в качестве вакцин
JP2012125257A5 (https=)
Sanders et al. Brunenders: a partially attenuated historic poliovirus type I vaccine strain
CN108055827B (zh) 高成长肠病毒71型病毒株及其疫苗
CN102657857B (zh) 一种利用沙鼠肾细胞制备肠道病毒疫苗的方法
TW200914616A (en) Two-step temperature profile for the propagation of viruses
Zimina et al. Viral vector-driven trans-encapsidation of replicon RNAs as a rapid approach for the development of safe and economically attractive anti-enterovirus vaccines